Daniel Blair, PhD, PhD
Assistant Member, St. Jude Faculty
St. Jude Children's Research Hospital
Daniel Blair, PhD, is an assistant faculty member in the Department of Chemical Biology and Therapeutics at St. Jude. View full bio.
Apoptosis or necroptosis? The caspase-8 protein decides
| Oct 20, 2017Programmed cell death can affect immune response to diseases such as cancer. Learn how caspase-8 chooses cell death and how that decision can be stopped.
Learn moreRigor, reproducibility and resources take center stage
| Jun 27, 2017NIH seminar elucidates new guidelines for grant-funded research as well as allocation of monies to more labs.
Learn moreWhy does the risk of pediatric acute lymphoblastic leukemia relapse vary by race?
| Mar 28, 2017These inherited gene variations may help explain why the risk of relapse for children with acute lymphoblastic leukemia varies by race.
Learn moreCell necroptosis: Can ESCRT-III proteins protect cells from the kill switch?
| Aug 17, 2017Find out how a newly discovered protein can give your body’s doomed cells a second chance at life.
Learn moreBrain studies provide treatment clues in unexpected fields
| Nov 29, 2017Research shows possible path to restoring critical regions of the brain involved with hearing loss by limiting a neuromodulator in the auditory thalamus.
Learn moreMedulloblastoma and microirradiation: Tiny treatments for the most common malignant pediatric brain tumor
| Feb 18, 2019Medulloblastoma may soon be treated by a microirradiator - a machine the size of two refrigerators that beams radiation down to half the width of a credit card.
Learn moreBlazing through new territory to fight a devastating neurodegenerative disease
| Jan 17, 2019Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.
Learn moreGenetic sequencing: How do we put out the fires of genetically driven cancers?
| Nov 8, 2019Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.
Learn moreOptimizing leukemia treatment through pharmaceutical science
| Jun 19, 2019Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.
Learn moreSeparating fact from fiction using pharmacogenetics
| Oct 8, 2019Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.
Learn more